Fenofibric Acid (trilipix).
D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D017277:Drug Approval; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000188:drug therapy*; D011345:Fenofibrate / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000494:pharmacology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; C006012:fenofibric acid; D011345:Fenofibrate